Anti-CD21 Antibody [SC0681]
ET1610-61
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetCR2
Overview
- SupplierHUABIO
- Product NameAnti-CD21 Antibody [SC0681]
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- Applications SupplierWB,IF-Cell,IHC-P,IP
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSC0681
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID1380
- Target nameCR2
- Target descriptioncomplement C3d receptor 2
- Target synonymsC3DR, CD21, CR, CVID7, SLEB9, complement receptor type 2, EBV receptor, complement component (3d/Epstein Barr virus) receptor 2, complement component 3d receptor 2
- HostRabbit
- IsotypeIgG
- Protein IDP19070
- Protein NameComplement receptor type 2
- Scientific DescriptionCD21 is a type I integral membrane glycoprotein that serves as a receptor for the C3d complement fragment and for the Epstein-Barr virus. It plays a role in B cell activation and proliferation and undergoes phosphorylation after B cell activation with phorbol esters. CD21 is expressed on mature B cells, follicular dendritic cells, pharyngeal and cervical epithelial cells and a subset of thymocytes. The adaptive immune response is tightly regulated to limit responding cells in an antigen-specific manner. On B cells, co-receptors CD21/CD19 modulate the strength of B cell Ag receptor (BCR) signals, thereby influencing cell fate. Complement receptor (CR) type 2 (CR2/ CD21) is normally expressed during the immature and mature stages of B cell development. In association with CD19, CR21 plays an important role in enhancing mature B cell responses to foreign antigens.
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteMouse
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161